Bringing a new cell therapy treatment to market requires innovative and compliant solutions that can accelerate progress from the lab, all the way to the patient, safely and cost effectively. To streamline regulatory submission and smooth the transition from R&D toward manufacturing, it is crucial to maintain comprehensive and precise electronic records from the lab equipment used. Learn about solutions that can simplify 21 CFR Part 11 compliance in a cell therapy workflow.
Please check the highlighted fields and try again.
Please fill out the information below. If you are already registered, login and this information will be filled out for you.
Please enter the name of the company or institution you work at.
Please enter your mailing address.
Please enter the e-mail address you would like to be contacted at.
Please enter the phone number you would like to be contacted at.
Would you like to hear from a live-cell analysis expert to discuss your research needs?*
I confirm that I have read the Declaration of Consent regarding the data processing for marketing purposes by Sartorius (Sartorius AG and its affiliated companies) and consent to this processing.
By submitting this form, you consent to American Pharmaceutical Review storing your email address and contact information and transmitting your contact information to the content sponsor. You may request to be removed at any time.